Search Result

Isoforms Recommended:	ASCT1

Results for "

ASCT1

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ASCT (2) CXCR (2) Small Interfering RNA (siRNA) (3)
By Research Areas:	Cancer (4) Cardiovascular Disease (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Oligonucleotides

Targets Recommended: ASCT

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-112683

V-9302 Maximum Cited Publications 34 Publications Verification	ASCT	Cancer
V-9302 is a competitive antagonist of transmembrane glutamine flux. V-9302 selectively and potently targets the amino acid transporter **ASCT2 (SLC1A5)** not ASCT1. V-9302 inhibits ASCT2-mediated glutamine uptake (IC₅₀=9.6 μM) in HEK-293 cells ^[1].

HY-112683A

V-9302 hydrochloride Maximum Cited Publications 34 Publications Verification	ASCT	Cancer
V-9302 hydrochloride is a competitive antagonist of transmembrane glutamine flux. V-9302 hydrochloride selectively and potently targets the amino acid transporter **ASCT2 (SLC1A5)** not ASCT1. V-9302 hydrochloride inhibits ASCT2-mediated glutamine uptake (IC₅₀=9.6 µM) in HEK-293 cells ^[1].

HY-19867A

Burixafor hydrobromide TG-0054 hydrobromide	CXCR	Cardiovascular Disease Cancer
Burixafor (TG-0054) hydrobromide is a potent CXCR4 antagonist with a pIC₅₀ of 7.4. Burixafor hydrobromide inhibits the binding of CXCL12 to CXCR4, antagonizes CXCL12-induced recruitment of Gαᵢ and β-arrestin2, and blocks the downstream Gαᵢ-mediated inhibitory effect on cAMP signal transduction. Burixafor hydrobromide mobilizes CD34 ⁺ hematopoietic stem/progenitor cells (HSPC) from the bone marrow to the peripheral blood. Burixafor hydrobromide can be used for research on autologous hematopoietic stem cell transplantation (ASCT) .

HY-RS21934

Slc1a4 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Slc1a4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Slc1a4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Slc1a4 Mouse Pre-designed siRNA Set A Slc1a4 Mouse Pre-designed siRNA Set A

HY-RS13055

SLC1A4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
SLC1A4 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC1A4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLC1A4 Human Pre-designed siRNA Set A SLC1A4 Human Pre-designed siRNA Set A

HY-RS28450

Slc1a4 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Slc1a4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Slc1a4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Slc1a4 Rat Pre-designed siRNA Set A Slc1a4 Rat Pre-designed siRNA Set A

HY-19867

Burixafor TG-0054	CXCR	Cancer
Burixafor (TG-0054) is a potent CXCR4 antagonist with a pIC₅₀ of 7.4. Burixafor inhibits the binding of CXCL12 to CXCR4, antagonizes CXCL12-induced recruitment of Gαᵢ and β-arrestin2, and blocks the downstream Gαᵢ-mediated inhibitory effect on cAMP signal transduction. Burixafor mobilizes CD34 ⁺ hematopoietic stem/progenitor cells (HSPC) from the bone marrow to the peripheral blood. Burixafor can be used for research on autologous hematopoietic stem cell transplantation (ASCT) .

Slc1a4 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Slc1a4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Slc1a4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLC1A4 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
SLC1A4 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC1A4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Slc1a4 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Slc1a4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Slc1a4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

MedchemExpress Validation 03

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred

MedchemExpress Validation 04

MedchemExpress Validation

We use cookies

MedChemExpress values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Privacy and Cookie Policy

Name
Email *

	Sorry, but the email address you supplied was invalid.